Comment on

• Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding.

  Amin AP, Marso SP, Rao SV, Messenger J, Chan PS, House J, Kennedy K, Robertus K, Cohen DJ, Mahoney EM. Amin AP, et al. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):358-65. doi: 10.1161/CIRCOUTCOMES.110.957290. Epub 2010 May 20. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20488917
• Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients.

  Maddox TM, Ross C, Tavel HM, Lyons EE, Tillquist M, Ho PM, Rumsfeld JS, Margolis KL, O'Connor PJ, Selby JV, Magid DJ. Maddox TM, et al. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):347-57. doi: 10.1161/CIRCOUTCOMES.110.957308. Epub 2010 May 20. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20488918 Free PMC article.
• Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction.

  Salisbury AC, Alexander KP, Reid KJ, Masoudi FA, Rathore SS, Wang TY, Bach RG, Marso SP, Spertus JA, Kosiborod M. Salisbury AC, et al. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):337-46. doi: 10.1161/CIRCOUTCOMES.110.957050. Epub 2010 May 20. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20488919 Free PMC article. Clinical Trial.